β-Amyloid triggers ALS-associated TDP-43 pathology in AD models

Brain Research

Volumn 1386, Issue , 2011, Pages 191-199

  Herman, Alexander M ^a   Khandelwal, Preeti J ^a   Stanczyk, Brenna B ^a   Rebeck, G William ^a   Moussa, Charbel E H ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

amyloid; Synuclein; AD; ALS; FTLD; PD; Tau; TDP 43

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CASEIN KINASE; LENTIVIRUS VECTOR; TAR DNA BINDING PROTEIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN; BRAIN CORTEX; CYTOSOL; DISEASE COURSE; GENE TRANSFER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LENTIVIRINAE; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MOTOR CORTEX; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

MUS; RATTUS;

EID: 79953882939     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.02.052     Document Type: Article

References (63)

1. Amador-Ortiz, C., Lin, W.L., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff-Radford, N.R., Hutton, M.L., Dickson, D.W., 2007. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61, 435-445.
2. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., Oda, T., 2006. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611.
3. Ardley, H.C., Tan, N.G., Rose, S.A., Markham, A.F., Robinson, P.A., 2001. Features of the parkin/ariadne-like ubiquitin ligase, HHARI, that regulate its interaction with the ubiquitin-conjugating enzyme, Ubch7. J. Biol. Chem. 276, 19640-19647.
4. Ayala, Y.M., Pantano, S., D'Ambrogio, A., Buratti, E., Brindisi, A., Marchetti, C., Romano, M., Baralle, F.E., 2005. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 348, 575-588.
5. Bennett, M.C., Bishop, J.F., Leng, Y., Chock, P.B., Chase, T.N., Mouradian, M.M., 1999. Degradation of alpha-synuclein by proteasome. J. Biol. Chem. 274, 33855-33858.
6. Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y.M., Baralle, F.E., 2005. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280, 37572-37584.
7. Buratti, E., Baralle, F.E., 2008. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 13, 867-878.
8. Burns, M.P., Zhang, L., Rebeck, G.W., Querfurth, H.W., Moussa, C.E., 2009. Parkin promotes intracellular Abeta1-42 clearance. Hum. Mol. Genet. 18, 3206-3216.
9. Caccamo, A., Majumder, S., Deng, J.J., Bai, Y., Thornton, F.B., Oddo, S., 2009. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J. Biol. Chem. 284, 27416-27424.
10. Caccamo, A., Magri, A., Oddo, S., 2010. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Abeta oligomers accumulation. Mol. Neurodegener. 5, 51.
11. Cook, D.G., Forman, M.S., Sung, J.C., Leight, S., Kolson, D.L., Iwatsubo, T., Lee, V.M., Doms, R.W., 1997. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3, 1021-1023.
12. Davidson, Y., Kelley, T., Mackenzie, I.R., Pickering-Brown, S., Du Plessis, D., Neary, D., Snowden, J.S., Mann, D.M., 2007. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol. 113, 521-533. (Pubitemid 46672598)
13. Forman, M.S., Farmer, J., Johnson, J.K., Clark, C.M., Arnold, S.E., Coslett, H.B., Chatterjee, A., Hurtig, H.I., Karlawish, J.H., Rosen, H.J., Van Deerlin, V., Lee, V.M., Miller, B.L., Trojanowski, J.Q., Grossman, M., 2006. Frontotemporal dementia: clinicopathological correlations. Ann. Neurol. 59, 952-962.
14. Geser, F., Winton, M.J., Kwong, L.K., Xu, Y., Xie, S.X., Igaz, L.M., Garruto, R.M., Perl, D.P., Galasko, D., Lee, V.M., Trojanowski, J.Q., 2008. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 115, 133-145. (Pubitemid 350238671)
15. Gitcho, M.A., Baloh, R.H., Chakraverty, S., Mayo, K., Norton, J.B., Levitch, D., Hatanpaa, K.J., White III, C.L., Bigio, E.H., Caselli, R., Baker, M., Al-Lozi, M.T., Morris, J.C., Pestronk, A., Rademakers, R., Goate, A.M., Cairns, N.J., 2008. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 63, 535-538.
16. Gouras, G.K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J.P., Haroutunian, V., Buxbaum, J.D., Xu, H., Greengard, P., Relkin, N.R., 2000. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156, 15-20.
17. Greenfield, J.P., Tsai, J., Gouras, G.K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S.S., Greengard, P., Xu, H., 1999. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl Acad. Sci. USA 96, 742-747.
18. Gros-Louis, F., Gaspar, C., Rouleau, G.A., 2006. Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762, 956-972.
19. Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B., et al., 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
20. Hanihara, T., Amano, N., Takahashi, T., Nagatomo, H., Yagashita, S., 1995. Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol. Appl. Neurobiol. 21, 319-326.
21. Hardy, J., Selkoe, D.J., 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
22. Hasegawa, M., Arai, T., Akiyama, H., Nonaka, T., Mori, H., Hashimoto, T., Yamazaki, M., Oyanagi, K., 2007. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130, 1386-1394. (Pubitemid 47355958)
23. Hasegawa, M., Arai, T., Nonaka, T., Kametani, F., Yoshida, M., Hashizume, Y., Beach, T.G., Buratti, E., Baralle, F., Morita, M., Nakano, I., Oda, T., Tsuchiya, K., Akiyama, H., 2008. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60-70.
24. Hof, P.R., Delacourte, A., Bouras, C., 1992. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol. 84, 45-51.
25. Hyun, D.H., Lee, M., Hattori, N., Kubo, S., Mizuno, Y., Halliwell, B., Jenner, P., 2002. Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J. Biol. Chem. 277, 28572-28577.
26. Ito, K., Arai, K., Yoshiyama, Y., Kashiwado, K., Sakakibara, Y., Hattori, T., 2008. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy. Acta Neuropathol. 115, 623-628.
27. Khandelwal, P.J., Dumanis, S.B., Feng, L.R., Maguire-Zeiss, K., Rebeck, G., Lashuel, H.A., Moussa, C.E., 2010. Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model. Mol. Neurodegener. 5, 47.
28. Koo, E.H., Squazzo, S.L., 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
29. Lee, S.J., Liyanage, U., Bickel, P.E., Xia, W., Lansbury Jr., P.T., Kosik, K.S., 1998. A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med. 4, 730-734.
30. Lee, V.M., Goedert, M., Trojanowski, J.Q., 2001. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
31. Lomen-Hoerth, C., Anderson, T., Miller, B., 2002. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59, 1077-1079.
32. Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J.H., Olney, R.K., Miller, B., 2003. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60, 1094-1097.
33. Mackenzie, I.R., Bigio, E.H., Ince, P.G., Geser, F., Neumann, M., Cairns, N.J., Kwong, L.K., Forman, M.S., Ravits, J., Stewart, H., Eisen, A., McClusky, L., Kretzschmar, H.A., Monoranu, C.M., Highley, J.R., Kirby, J., Siddique, T., Shaw, P.J., Lee, V.M., Trojanowski, J.Q., 2007. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427-434.
34. Morales, B., Martinez, A., Gonzalo, I., Vidal, L., Ros, R., Gomez-Tortosa, E., Rabano, A., Ampuero, I., Sanchez, M., Hoenicka, J., Garcia De Yebenes, J., 2002. Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein. Mov. Disord. 17, 1374-1380.
35. Morett, E., Bork, P., 1999. A novel transactivation domain in parkin. Trends Biochem. Sci. 24, 229-231.
36. Morita, M., Al-Chalabi, A., Andersen, P.M., Hosler, B., Sapp, P., Englund, E., Mitchell, J.E., Habgood, J.J., de Belleroche, J., Xi, J., Jongjaroenprasert, W., Horvitz, H.R., Gunnarsson, L.G., Brown Jr., R.H., 2006. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66, 839-844.
37. Murray, B., Lynch, T., Farrell, M., 2005. Clinicopathological features of the tauopathies. Biochem. Soc. Trans. 33, 595-599.
38. Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S.X., Hurtig, H., Duda, J.E., Arnold, S.E., Siderowf, A., Grossman, M., Leverenz, J.B., Woltjer, R., Lopez, O.L., Hamilton, R., Tsuang, D.W., Galasko, D., Masliah, E., Kaye, J., Clark, C.M., Montine, T.J., Lee, V.M., Trojanowski, J.Q., 2007. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114, 221-229. (Pubitemid 47226148)
39. Neary, D., Snowden, J.S., Mann, D.M., Northen, B., Goulding, P.J., Macdermott, N., 1990. Frontal lobe dementia and motor neuron disease. J. Neurol. Neurosurg. Psychiatry 53, 23-32.
40. Neary, D., Snowden, J.S., Mann, D.M., 2000. Classification and description of frontotemporal dementias. Ann. NY Acad. Sci. 920, 46-51.
41. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., McCluskey, L.F., Miller, B.L., Masliah, E., Mackenzie, I.R., Feldman, H., Feiden, W., Kretzschmar, H.A., Trojanowski, J.Q., Lee, V.M., 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. (Pubitemid 44547757)
42. Neumann, M., Kwong, L.K., Sampathu, D.M., Trojanowski, J.Q., Lee, V.M., 2007a. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch. Neurol. 64, 1388-1394.
43. Neumann, M., Mackenzie, I.R., Cairns, N.J., Boyer, P.J., Markesbery, W.R., Smith, C.D., Taylor, J.P., Kretzschmar, H.A., Kimonis, V.E., Forman, M.S., 2007b. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 66, 152-157.
44. Pasinelli, P., Brown, R.H., 2006. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723.
45. Ratnavalli, E., Brayne, C., Dawson, K., Hodges, J.R., 2002. The prevalence of frontotemporal dementia. Neurology 58, 1615-1621. (Pubitemid 34602891)
46. Rebeck, G.W., Hoe, H.S., Moussa, C.E., 2010. beta]-Amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss. J. Biol. Chem.
47. Ros, R., Ampuero, I., Garcia de Yebenes, J., 2008. Parkin polymorphisms in progressive supranuclear palsy. J. Neurol. Sci. 268, 176-178.
48. Rosen, D.R., 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364, 362. (Pubitemid 23265284)
49. Sanchez, M.P., Gonzalo, I., Avila, J., De Yebenes, J.G., 2002. Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation. J. Alzheimers Dis. 4, 399-404. (Pubitemid 35397805)
50. Skovronsky, D.M., Doms, R.W., Lee, V.M., 1998. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J. Cell Biol. 141, 1031-1039. (Pubitemid 28243969)
51. Snowden, J.S., Neary, D., Mann, D.M., 2002. Frontotemporal dementia. Br. J. Psychiatry 180, 140-143. (Pubitemid 34142785)
52. Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J.C., Williams, K.L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J.D., Leigh, P.N., Al-Chalabi, A., Miller, C.C., Nicholson, G., Shaw, C.E., 2008. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672. (Pubitemid 351432505)
53. Talbot, K., Ansorge, O., 2006. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease. Hum. Mol. Genet. 15 Spec No 2, R182-R187.
54. Tan, C.F., Eguchi, H., Tagawa, A., Onodera, O., Iwasaki, T., Tsujino, A., Nishizawa, M., Kakita, A., Takahashi, H., 2007. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol. 113, 535-542. (Pubitemid 46672599)
55. Tofaris, G.K., Layfield, R., Spillantini, M.G., 2001. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509, 22-26. (Pubitemid 33153074)
56. van de Warrenburg, B.P., Lammens, M., Lucking, C.B., Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A., Horstink, M.W., 2001. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 56, 555-557. (Pubitemid 32172889)
57. Wang, H.Y., Wang, I.F., Bose, J., Shen, C.K., 2004. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83, 130-139. (Pubitemid 37518267)
58. Wegorzewska, I., Bell, S., Cairns, N.J., Miller, T.M., Baloh, R.H., 2009. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 106, 18809-18814.
59. Wilson, C.A., Doms, R.W., Lee, V.M., 1999. Intracellular APP processing and A beta production in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58, 787-794.
60. Winton, M.J., Igaz, L.M., Wong, M.M., Kwong, L.K., Trojanowski, J.Q., Lee, V.M., 2008. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302-13309.
61. Xu, H., Sweeney, D., Wang, R., Thinakaran, G., Lo, A.C., Sisodia, S.S., Greengard, P., Gandy, S., 1997. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl Acad. Sci. USA 94, 3748-3752.
62. Zhang, Y.J., Xu, Y.F., Dickey, C.A., Buratti, E., Baralle, F., Bailey, R., Pickering-Brown, S., Dickson, D., Petrucelli, L., 2007. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530-10534. (Pubitemid 47501990)
63. Zhang, Y.J., Xu, Y.F., Cook, C., Gendron, T.F., Roettges, P., Link, C.D., Lin, W.L., Tong, J., Castanedes-Casey, M., Ash, P., Gass, J., Rangachari, V., Buratti, E., Baralle, F., Golde, T.E., Dickson, D.W., Petrucelli, L., 2009. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 106, 7607-7612.